IBD Stock Of The Day Halozyme Eyes Two Buy Points; How It's 'Layering' Up For Future Growth

Halozyme, IBD Stock Of The Day, Near Buy Point; Why It's A Story Of 'Layering And Duration' | Investor's Business DailyBREAKING: [Futures Mixed: AMD, Lumentum Lead Earnings Latel----Halozyme Therapeutics Halozyme Therapeutics HALO $ 75.36 $0.91 1.22% 15% IBD Stock Analysis Stock with 74.2.5 double bottom buy point HALO investors should probably use 75.59 handle entry Composite Rating 99/99 Industry Group Ranking 8/197 Emerging Pattern Double Bottom Double Bottom One of the three positive chart patterns to l ...